{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:58:09Z","timestamp":1791136689928,"version":"4.1.0"},"reference-count":52,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.2217\/pgs.12.202","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T16:27:07Z","timestamp":1358440027000},"page":"137-149","source":"Crossref","is-referenced-by-count":57,"title":["<i>CYP3A4<\/i>Intron 6 C&gt;T SNP (<i>CYP3A4*22<\/i>) Encodes Lower CYP3A4 Activity in Cancer Patients, as Measured with Probes Midazolam and Erythromycin"],"prefix":"10.1080","volume":"14","author":[{"given":"Laure","family":"Elens","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry, Erasmus University Medical Center, PO Box 2040, 3000CA Rotterdam, The Netherlands"},{"name":"Louvain Centre for Toxicology &amp; Applied Pharmacology, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Nieuweboer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Clarke","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie A","family":"Charles","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Joy","family":"de Graan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[{"name":"Louvain Centre for Toxicology &amp; Applied Pharmacology, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron HJ","family":"Mathijssen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron HN","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Erasmus University Medical Center, PO Box 2040, 3000CA Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"e_1_3_4_3_1_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200023337054"},{"key":"e_1_3_4_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00066-2"},{"key":"e_1_3_4_3_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.462"},{"key":"e_1_3_4_3_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0752"},{"key":"e_1_3_4_3_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.6.755"},{"key":"e_1_3_4_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)45600-1"},{"key":"e_1_3_4_3_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.2572"},{"key":"e_1_3_4_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200007000-00001"},{"key":"e_1_3_4_3_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1371"},{"key":"e_1_3_4_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70037-8"},{"key":"e_1_3_4_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200310000-00003"},{"key":"e_1_3_4_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.11.112"},{"key":"e_1_3_4_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100237"},{"key":"e_1_3_4_3_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0520"},{"key":"e_1_3_4_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2009.21"},{"key":"e_1_3_4_3_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.12.1491"},{"key":"e_1_3_4_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0503-9"},{"key":"e_1_3_4_3_18_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.108506"},{"key":"e_1_3_4_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2010.28"},{"key":"e_1_3_4_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834c6edb"},{"key":"e_1_3_4_3_21_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.165613"},{"key":"e_1_3_4_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328351f3c1"},{"key":"e_1_3_4_3_23_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.90"},{"key":"e_1_3_4_3_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/11317550-000000000-00000"},{"key":"e_1_3_4_3_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/11317350-000000000-00000"},{"key":"e_1_3_4_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.08.035"},{"key":"e_1_3_4_3_27_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2003.23"},{"key":"e_1_3_4_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200004000-00001"},{"key":"e_1_3_4_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90543-6"},{"key":"e_1_3_4_3_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.008904"},{"key":"e_1_3_4_3_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.7.938"},{"key":"e_1_3_4_3_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140030-00001"},{"key":"e_1_3_4_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)90132-8"},{"key":"e_1_3_4_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200207"},{"key":"e_1_3_4_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-9236(95)90261-9"},{"key":"e_1_3_4_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.174"},{"key":"e_1_3_4_3_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199408000-00001"},{"key":"e_1_3_4_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.126"},{"key":"e_1_3_4_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90146-1"},{"issue":"1","key":"e_1_3_4_3_40_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-895X(25)09118-7","volume":"36","author":"Kronbach T","year":"1989","unstructured":"Kronbach T , MathysD, UmenoM, GonzalezFJ, MeyerUA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol. Pharmacol.36(1) , 89\u201396 (1989).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_4_3_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/73.5.658"},{"issue":"2","key":"e_1_3_4_3_42_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0026-895X(25)09441-6","article-title":"Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).","volume":"38","author":"Wrighton SA","year":"1990","unstructured":"Wrighton SA , BrianWR, SariMA et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38(2) , 207\u2013213 (1990).","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"e_1_3_4_3_43_1","first-page":"1255","volume":"6","author":"Hirth J","year":"2000","unstructured":"Hirth J , WatkinsPB, StrawdermanM, SchottA, BrunoR, BakerLH. The effect of an individual\u2018s cytochrome CYP3A4 activity on docetaxel clearance. Clin. Cancer Res.6(4) , 1255\u20131258 (2000).","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"e_1_3_4_3_44_1","first-page":"3480","article-title":"Optimizing the erythromycin breath test for use in cancer patients.","volume":"6","author":"Rivory LP","year":"2000","unstructured":"Rivory LP , SlavieroK, SealeJP et al. Optimizing the erythromycin breath test for use in cancer patients. Clin. Cancer Res. 6(9) , 3480\u20133485 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_4_3_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1526"},{"key":"e_1_3_4_3_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh298"},{"key":"e_1_3_4_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.004"},{"key":"e_1_3_4_3_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011418"},{"key":"e_1_3_4_3_49_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP201701"},{"key":"e_1_3_4_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.02.005"},{"key":"e_1_3_4_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.06.002"},{"key":"e_1_3_4_3_52_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.4.863"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.12.202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:29:13Z","timestamp":1745947753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.12.202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.2217\/pgs.12.202"],"URL":"https:\/\/doi.org\/10.2217\/pgs.12.202","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}